Indian markets started 2012 on a positive note. Ridham Desai, managing director and strategist and head of India equity research, Morgan Stanley, says, he expects a 15 per cent upside in the Sensex this year.
While domestic sales in the second quarter are expected to be weak for major players, Lupin is likely to outperform the pharma sector on the back of a growing chronic portfolio.
Severe price cuts help multinationals ramp up growth, gain market share.
Aggressive smaller players are serving a bitter pill to the big boys in the pharmaceutical sector.
Footfalls increase at retail outlets and auto dealers, but conversions fall.
Given the recent weakness in the rupee and the high forward premium, information technology companies can prove to be good defensive stocks with low downside risks in the prevailing market conditions, Moses Harding, head (global markets group), IndusInd Bank, tells Puneet Wadhwa.
The key triggers would be price of oil, inflation and results of state elections. If oil and inflation levels come down, there could be a rally.
Companies together have lost about Rs 20,000 crore (Rs 200 billion) in market value since the arrest of former telecom minister, A Raja, leading to historically low valuations.
India's largest pharma companies by market capitalisation Sun Pharma, Dr Reddy's and Cipla have seen their share prices drop 5-20 per cent over the last two weeks on results that were below Street expectations.
We believe equity markets in 2011 will be volatile. However, for investors, volatility will provide investment opportunities.
The BSE Realty index fell 11 per cent over the last month and eight per cent over the week as real estate companies reported margin pressures in the September quarter.
The Street has welcomed the sustained demand and higher sales for two-wheeler makers in September by pushing up stock prices of the three key companies by three to seven per cent over the past week.
While demand for consumer durables has been growing fast, investors need to be selective as stock valuations have risen even faster.
India, per se, is witnessing more promising growth.
With the broader indices continuing to power ahead and valuations trading at a premium, investors tend to look at small and mid-cap companies for bargains.
Following a strategy that is different from the herd could help increase returns in a market trading at premium valuations.
A rise in consumer confidence, improvement in profitability and aggressive expansion plans signal better tidings for listed players in the organised retail space.
Anuj Puri, chairman and country head, Jones Lang LaSalle Meghraj, tells Business Standard that high prices and hardening of mortgage rates may act as a dampener.
Fund houses bet on growth, divestment and deregulation.
The central bank may increase both repo and reverse repo rates by another 25 basis points each in the next policy meeting.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances